Cardiometabolic consequences of targeted anticancer therapies.

A Guha, Y Gong, D DeRemer, J Owusu-Guha, SF Dent, RK Cheng, NL Weintraub, N Agarwal, MG Fradley

Research output: Contribution to journal › Article › peer-review

Original language	Undefined
Journal	Journal of Cardiovascular Pharmacology
DOIs	https://doi.org/10.1097/fjc.0000000000001149
State	Published - Oct 2021

Access to Document

@article{5f18e30b062b4a178570ac5d60c34077,

title = "Cardiometabolic consequences of targeted anticancer therapies.",

author = "A Guha and Y Gong and D DeRemer and J Owusu-Guha and SF Dent and RK Cheng and NL Weintraub and N Agarwal and MG Fradley",

year = "2021",

month = oct,

doi = "10.1097/fjc.0000000000001149",

language = "Undefined",

journal = "Journal of Cardiovascular Pharmacology",

issn = "0160-2446",

publisher = "Lippincott Williams and Wilkins",

}

TY - JOUR

T1 - Cardiometabolic consequences of targeted anticancer therapies.

AU - Guha, A

AU - Gong, Y

AU - DeRemer, D

AU - Owusu-Guha, J

AU - Dent, SF

AU - Cheng, RK

AU - Weintraub, NL

AU - Agarwal, N

AU - Fradley, MG

PY - 2021/10

Y1 - 2021/10

UR - http://europepmc.org/abstract/med/34654781

U2 - 10.1097/fjc.0000000000001149

DO - 10.1097/fjc.0000000000001149

M3 - Article

C2 - 34654781

JO - Journal of Cardiovascular Pharmacology

JF - Journal of Cardiovascular Pharmacology

SN - 0160-2446

ER -